绥美凯是哪个国家产的？

In January 2018, it was launched in China and is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV). Which country is Suimeikai produced in?

Suimeikai manufacturer: ViiV Healthcare, a joint venture company affiliated with British GlaxoSmithKline (GSK)

The domestic price of Suimeikai’s original drug is 2,880$/box. The price is the lowest among surrounding countries and regions.

Since Suimeikai is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikai, which is launched in India.

Suimeike generic drug manufacturer: Indian pharmaceutical factory

Suimeikai, produced by the Indian company Emcure, comes in a box of 30 tablets and sells for about RMB 1,000. The price cannot be determined due to the floating exchange rate. Please consult Medical Travel for the specific price.

In addition, you need to pay attention to the following when using Suimeikai:

HIV-infected patients, regardless of race, should be screened for the HLA-B*5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the RLA-B*5701 allele, he should not take products containing abacavir.

Spread HIV

Although effective viral suppression with antiretroviral therapy has been shown to significantly reduce the risk of sexual transmission, residual risks cannot be excluded. Precautions should be taken to prevent transmission in accordance with national guidance.

hypersensitivity reaction

Both abacavir and dolutegravir carry the risk of triggering a hypersensitivity reaction (HSR) and share some common characteristics, such as fever and/or rash and other symptoms indicating involvement of multiple organs. It is unlikely to be clinically possible to determine whether a hypersensitivity reaction occurring during use is caused by abacavir or dolutegravir.

Recommended related hot articles: /newsDetail/71883.html